Measuring the Effect of Radiation Therapy on Patient Activity Levels

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02694380

Enrollment

Registered

2016-02-29

Start date

2015-07-31

Completion date

2018-07-31

Last updated

2018-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Head and Neck Cancer, Lung Cancer, Prostate Cancer

Brief summary

The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.

Detailed description

At the University of Pittsburgh (UPMC) St. Margaret and UPMC Shadyside, in the department of radiation oncology, breast, prostate, head and neck, and lung cancer patients will receive the standard treatment for their cancer and in no way will this study interfere with this treatment. Prior to initiation of radiation, consenting patients will be given Misfit activity tracking devices (accelerometers) to be worn on their wrist to track their activity levels throughout the course radiation therapy. Bracelets will be given to patients by the PI or co-investigators (MDs involved in patient's care) at date of consent and returned at completion of the study. The bracelets will track daily steps taken, calories burned, miles walked, and restful and restless sleep. Again, the purpose of the study is merely to measure the affect radiation therapy has on activity levels of patients.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of Breast, Prostate, Lung or Head and Neck Cancer * Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 * Ability to walk 100 feet without rest * Signed informed consent

Exclusion criteria

* Any other noncutaneous cancer diagnosis under active treatment * Known metastatic disease

Design outcomes

Primary

Measure	Time frame	Description
Activity level	up to 15 weeks	Misfit activity tracking devices (accelerometers) will be worn by patients to track their activity levels 1 day to 4 weeks before radiotherapy, during radiotherapy, and for 1 day to 4 weeks after radiotherapy.

Countries

United States

Outcome results